Dr. S. K. Siddha Medicine Professional Corporation | Newmarket, Canada

Research site
679 Davis Drive Suite 205, Newmarket, Ontario, Canada
Site insights

Top conditions

Hidradenitis (3 trials)

Hidradenitis Suppurativa (3 trials)

Atopic Dermatitis (2 trials)

Alopecia Areata (2 trials)

Alopecia (2 trials)

Top treatments


Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


5 of 9
Status: Active
Trial type: Interventional
Funder type: Industry

A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-SHUTTLE)

The coprimary objectives of the study are to:evaluate the efficacy of rocatinlimab in combination with topical corticosteroid and/or topical calcineu...

Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab

This study is open to adults with hidradenitis suppurativa who took part in a previous clinical study of a medicine called spesolimab. Participants w...

Active, not recruiting
Hidradenitis Suppurativa
Drug: Spesolimab

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in a...

Alopecia Areata
Drug: CTP-543

This study is open to adults with moderate to severe hidradenitis suppurativa (HS). The purpose of this study is to find out whether a medicine calle...

Hidradenitis Suppurativa
Drug: Placebo matching Spesolimab Formulation 2
Drug: Placebo matching Spesolimab Formulation 1

Trial sponsors

Amgen logo

Amgen (3 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems